Rob Aarnoutse, PharmD PhD, is associate professor, hospital pharmacist and clinical pharmacologist, working at the Department of Pharmacy and with the Radboud Institute for Health Sciences at Radboud university medical center, Nijmegen, The Netherlands.
His research is focused on drug treatment of tuberculosis (TB), HIV and TB/HIV co-infection. The central concept in his work is that efficacy and toxicity of drugs are dependent on drug concentrations achieved either systemically or locally. His research portfolio reaches from molecular pharmacological research to murine pharmacological studies, to pharmacokinetic studies in humans and clinical trials. Typical topics of interest are adherence, pharmacokinetics, pharmacodynamics, safety/tolerability and effectiveness of TB drugs, antiretrovirals, other anti-infective drugs and immunosuppressants. His research is performed in collaboration with colleagues in The Netherlands, Indonesia, Tanzania, South Africa and other countries.
Rob Aarnoutse headed the Pharmacokinetic & Therapeutic Drug Monitoring Laboratory at Radboud university medical center for several years, is member of the Chief Investigator Group of the PanACEA TB consortium, and developed international proficiency testing programs for bio-analysis of TB drugs and antiretroviral drugs.
